Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 2,873 Shares of Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,873 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53. Following the completion of the transaction, the chief operating officer now owns 779,993 shares of the company’s stock, valued at approximately $20,755,613.73. The trade was a 0.37 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Trading Up 5.3 %

PHR stock opened at $28.42 on Thursday. The firm has a fifty day moving average price of $22.50 and a 200 day moving average price of $22.53. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $29.16. The firm has a market cap of $1.65 billion, a PE ratio of -19.33 and a beta of 0.94. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted ($0.58) EPS. Sell-side analysts anticipate that Phreesia, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Large investors have recently added to or reduced their stakes in the stock. Franklin Resources Inc. lifted its stake in shares of Phreesia by 3.0% in the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the last quarter. Geode Capital Management LLC raised its holdings in Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after buying an additional 55,934 shares during the period. M&T Bank Corp lifted its position in Phreesia by 4.6% in the third quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock worth $801,000 after buying an additional 1,535 shares during the last quarter. Barclays PLC lifted its position in Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock worth $2,163,000 after buying an additional 43,225 shares during the last quarter. Finally, XTX Topco Ltd purchased a new position in Phreesia during the third quarter worth $247,000. 92.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on PHR shares. Truist Financial raised their price target on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. KeyCorp lifted their target price on Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a report on Tuesday, December 10th. Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Finally, Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and boosted their target price for the stock from $24.00 to $32.00 in a report on Wednesday. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $30.64.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.